ID25651A - Senyawa-senyawa bisiklo [2.2.1] heptana dan senyawa-senyawa yang terkait - Google Patents

Senyawa-senyawa bisiklo [2.2.1] heptana dan senyawa-senyawa yang terkait

Info

Publication number: ID25651A
Authority: ID; Indonesia
Prior art keywords: heptings; bisiklo; commitments; compounds; related heptings
Prior art date: 1998-03-17

Application number

IDW20001811A

Other languages

English (en)

Indonesian (id)

Inventor

Bertrand Leo Chenard

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-17

Filing date

1999-03-04

Publication date

2000-10-19

1999-03-04 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2000-10-19 Publication of ID25651A publication Critical patent/ID25651A/id

Links

150000001875 compounds Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C229/50—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms being part of the same condensed ring system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Urology & Nephrology (AREA)
Ophthalmology & Optometry (AREA)
Addiction (AREA)
Vascular Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Indole Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Thiazole And Isothizaole Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

IDW20001811A 1998-03-17 1999-03-04 Senyawa-senyawa bisiklo [2.2.1] heptana dan senyawa-senyawa yang terkait ID25651A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US7834698P	1998-03-17	1998-03-17

Publications (1)

Publication Number	Publication Date
ID25651A true ID25651A (id)	2000-10-19

Family

ID=22143450

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW20001811A ID25651A (id)	1998-03-17	1999-03-04	Senyawa-senyawa bisiklo [2.2.1] heptana dan senyawa-senyawa yang terkait

Country Status (40)

Country	Link
US (1)	US6136861A (cs)
EP (1)	EP1064256B1 (cs)
JP (1)	JP3665567B2 (cs)
KR (1)	KR100372981B1 (cs)
CN (1)	CN1231461C (cs)
AP (1)	AP1116A (cs)
AR (1)	AR017236A1 (cs)
AT (1)	ATE272608T1 (cs)
AU (1)	AU753422B2 (cs)
BG (1)	BG104837A (cs)
BR (1)	BR9908850A (cs)
CA (1)	CA2321639C (cs)
CO (1)	CO5090835A1 (cs)
CZ (1)	CZ20003355A3 (cs)
DE (1)	DE69919142T2 (cs)
DZ (1)	DZ2745A1 (cs)
EA (1)	EA003946B1 (cs)
ES (1)	ES2224604T3 (cs)
GT (1)	GT199900040A (cs)
HR (1)	HRP20000611A2 (cs)
HU (1)	HUP0101031A3 (cs)
ID (1)	ID25651A (cs)
IL (1)	IL138342A0 (cs)
IS (1)	IS5592A (cs)
MA (1)	MA26614A1 (cs)
MY (1)	MY121047A (cs)
NO (1)	NO20004626L (cs)
NZ (1)	NZ506227A (cs)
OA (1)	OA11488A (cs)
PE (1)	PE20000339A1 (cs)
PL (1)	PL343278A1 (cs)
PT (1)	PT1064256E (cs)
SK (1)	SK13532000A3 (cs)
TN (1)	TNSN99039A1 (cs)
TR (1)	TR200002671T2 (cs)
TW (1)	TW509667B (cs)
UA (1)	UA53781C2 (cs)
WO (1)	WO1999047490A1 (cs)
YU (1)	YU53700A (cs)
ZA (1)	ZA992094B (cs)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000051590A2 (en) *	1999-03-04	2000-09-08	The Board Of Trustees Of The University Of Illinois	Neuropharmacological treatment of sleep-related breathing disorders
US6313159B1 (en)	1999-08-20	2001-11-06	Guilford Pharmaceuticals Inc.	Metabotropic glutamate receptor ligand derivatives as naaladase inhibitors
UA73981C2 (en) *	2000-03-10	2005-10-17	Merck Patent Gmbh	(r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
CA2442717A1 (en) *	2001-03-15	2002-09-26	Saegis Pharmaceuticals, Inc.	Methods for restoring cognitive function following systemic stress
US6750364B2 (en) *	2001-06-29	2004-06-15	Wyeth	Bridged tricyclic analogs of 2-(carboxycyclopropyl)glycine as inhibitors of glutamate transport
US6689905B2 (en)	2001-06-29	2004-02-10	Wyeth	Stereoisomers of 3-aminotricyclo[2.2.1.0(2.6)]heptane-1,3-dicarboxylic acid
US6689904B2 (en) *	2001-06-29	2004-02-10	Wyeth	Bridged tricyclic analogs of 2-(carboxycyclopropyl)glycine
US6562816B2 (en)	2001-08-24	2003-05-13	Pharmacia & Upjohn Company	Substituted-heteroaryl-7-aza[2.2.1]bicycloheptanes for the treatment of disease
US7232798B2 (en) *	2001-11-13	2007-06-19	Tran Loi H	Neuroprotection and neuroegenisis by administering cyclic prolyl glycine
FR2872045B1 (fr) *	2004-06-28	2006-09-29	Centre Nat Rech Scient Cnrse	Medicaments pour le traitement specifique de symptomes de la maladie de parkinson
AR059898A1 (es)	2006-03-15	2008-05-07	Janssen Pharmaceutica Nv	Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200900065A (en)	2007-03-07	2009-01-01	Janssen Pharmaceutica Nv	3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) *	2007-03-07	2008-12-01	Janssen Pharmaceutica Nv	3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
AU2008299921B2 (en)	2007-09-13	2012-03-01	Concert Pharmaceuticals, Inc.	Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof
SI2203439T1 (sl)	2007-09-14	2011-05-31	Ortho Mcneil Janssen Pharm	1',3'-disubstituirani 4-fenil-3,4,5,6-tetrahidro-2H-1'H-(1,4')bipiridinil-2'-oni
BRPI0817101A2 (pt)	2007-09-14	2017-05-09	Addex Pharmaceuticals Sa	4-(aril-x-fenil)-1h-piridin-2-onas 1,3-dissubstituídas
ES2409215T3 (es) *	2007-09-14	2013-06-25	Janssen Pharmaceuticals, Inc.	4-fenil-1H-piridin-2-onas 1-3-disustituidas
ES2637794T3 (es) *	2007-11-14	2017-10-17	Janssen Pharmaceuticals, Inc.	Derivados de imidazo[1,2-A]piridina y su uso como moduladores alostéricos positivos de receptores MGLUR2
ES2439291T3 (es)	2008-09-02	2014-01-22	Janssen Pharmaceuticals, Inc.	Derivados de 3-azabiciclo[3.1.0]hexilo como moduladores de receptores de glutamato metabotrópicos
CA2738849C (en)	2008-10-16	2016-06-28	Addex Pharma S.A.	Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
ES2401691T3 (es)	2008-11-28	2013-04-23	Ortho-Mcneil-Janssen Pharmaceuticals, Inc.	Derivados de indol y de benzoxacina como moduladores de los receptores metabotrópicos de glutamato
ES2440001T3 (es)	2009-05-12	2014-01-27	Janssen Pharmaceuticals, Inc.	Derivados de 1,2,4-triazolo[4,3-A]piridina y su uso para el tratamiento o prevención de trastornos neurológicos y psiquiátricos
MY153913A (en)	2009-05-12	2015-04-15	Janssen Pharmaceuticals Inc	7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
SG176018A1 (en)	2009-05-12	2011-12-29	Janssen Pharmaceuticals Inc	1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
ES2552455T3 (es)	2010-11-08	2015-11-30	Janssen Pharmaceuticals, Inc.	Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
CA2814998C (en)	2010-11-08	2019-10-29	Janssen Pharmaceuticals, Inc.	1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CN103298809B (zh)	2010-11-08	2016-08-31	杨森制药公司	1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
TWI520935B (zh)	2010-11-18	2016-02-11	美國禮來大藥廠	作為ｍＧｌｕＲ２／３拮抗劑之４－經取代－３－苯基磺醯基甲基－雙環［３.１.０］己烷化合物
KR101554793B1 (ko)	2010-11-18	2015-09-21	일라이 릴리 앤드 캄파니	mGluR 2／3 길항제로서의 4-치환된-3-벤질옥시-비시클로［3.1.0］헥산 화합물
KR102243637B1 (ko)	2013-03-14	2021-04-26	리커리엄 아이피 홀딩스, 엘엘씨	바이사이클릭 진통 화합물
JO3368B1 (ar)	2013-06-04	2019-03-13	Janssen Pharmaceutica Nv	مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar)	2013-09-06	2019-03-13	Janssen Pharmaceutica Nv	مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
EP3080072A4 (en)	2013-12-12	2017-07-19	Kalyra Pharmaceuticals, inc.	Bicyclic alkyl compounds and synthesis
US10537573B2 (en)	2014-01-21	2020-01-21	Janssen Pharmaceutica Nv	Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
IL279202B2 (en)	2014-01-21	2023-09-01	Janssen Pharmaceutica Nv	Combinations containing positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic subtype 2 receptor and their use
WO2015134710A1 (en)	2014-03-07	2015-09-11	Kalyra Pharmaceuticals, Inc.	Propellane derivates and synthesis
WO2016044331A1 (en)	2014-09-17	2016-03-24	Kalyra Pharmaceuticals, Inc.	Bicyclic compounds
WO2017160926A1 (en) *	2016-03-16	2017-09-21	Kalyra Pharmaceuticals, Inc.	Analgesic compounds
MX389668B (es)	2017-05-15	2025-03-20	Recurium Ip Holdings Llc	Compuestos biciclo[1.1.1]pentilo sustituidos y uso de los mismos para el tratamiento del dolor y fiebre.
AU2019271189A1 (en)	2018-05-15	2021-01-07	Lloyd Hung Loi TRAN	Therapeutic agent composition and method of use, for treatment of mild cognitive impairment, depression, and psychological disorders
KR102157141B1 (ko)	2018-11-27	2020-09-17	주식회사 파미니티	으아리 추출물을 유효 성분으로 포함하는 인지 기능 개선용 조성물
KR102172916B1 (ko)	2018-12-07	2020-11-02	주식회사 파미니티	실크 펩타이드 및 천연 추출물을 포함하는 인지 기능 개선용 조성물
US10844380B1 (en)	2019-06-17	2020-11-24	Biorchestra Co., Ltd.	Uses for prevention or treatment of brain diseases using microrna
US11198908B2 (en)	2019-06-17	2021-12-14	Biorchestra Co., Ltd.	Method for diagnosis of Alzheimer's disease using microRNA

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE199829T1 (de) *	1994-06-03	2001-04-15	Thejmde Trust	Meta substituierte arylalkylamine und therapeutische und diagnostische verwendung davon
PL182285B1 (pl) *	1994-08-12	2001-12-31	Lilly Co Eli	Syntetyczne aminokwasy oraz ich estry i srodki farmaceutyczne je zawierajace PL PL PL PL PL PL PL
GB9605429D0 (en) *	1995-11-16	1996-05-15	Lilly Co Eli	Excitatory amino acid receptor antagonists
WO1997017950A1 (en) *	1995-11-16	1997-05-22	Eli Lilly And Company	Shoulder prosthesis

1999
- 1999-03-04 CZ CZ20003355A patent/CZ20003355A3/cs unknown
- 1999-03-04 WO PCT/IB1999/000376 patent/WO1999047490A1/en not_active Ceased
- 1999-03-04 CN CNB998040401A patent/CN1231461C/zh not_active Expired - Fee Related
- 1999-03-04 ES ES99905122T patent/ES2224604T3/es not_active Expired - Lifetime
- 1999-03-04 CA CA002321639A patent/CA2321639C/en not_active Expired - Fee Related
- 1999-03-04 BR BR9908850-9A patent/BR9908850A/pt not_active Application Discontinuation
- 1999-03-04 EA EA200000842A patent/EA003946B1/ru not_active IP Right Cessation
- 1999-03-04 ID IDW20001811A patent/ID25651A/id unknown
- 1999-03-04 SK SK1353-2000A patent/SK13532000A3/sk unknown
- 1999-03-04 PL PL99343278A patent/PL343278A1/xx unknown
- 1999-03-04 EP EP99905122A patent/EP1064256B1/en not_active Expired - Lifetime
- 1999-03-04 AT AT99905122T patent/ATE272608T1/de not_active IP Right Cessation
- 1999-03-04 TR TR2000/02671T patent/TR200002671T2/xx unknown
- 1999-03-04 NZ NZ506227A patent/NZ506227A/xx unknown
- 1999-03-04 PT PT99905122T patent/PT1064256E/pt unknown
- 1999-03-04 JP JP2000536687A patent/JP3665567B2/ja not_active Expired - Fee Related
- 1999-03-04 IL IL13834299A patent/IL138342A0/xx unknown
- 1999-03-04 KR KR10-2000-7010264A patent/KR100372981B1/ko not_active Expired - Fee Related
- 1999-03-04 YU YU53700A patent/YU53700A/sh unknown
- 1999-03-04 DE DE69919142T patent/DE69919142T2/de not_active Expired - Fee Related
- 1999-03-04 HR HR20000611A patent/HRP20000611A2/hr not_active Application Discontinuation
- 1999-03-04 HU HU0101031A patent/HUP0101031A3/hu unknown
- 1999-03-04 AU AU25409/99A patent/AU753422B2/en not_active Ceased
- 1999-03-04 US US09/380,727 patent/US6136861A/en not_active Expired - Fee Related
- 1999-03-10 AP APAP/P/1999/001482A patent/AP1116A/en active
- 1999-03-12 TW TW088103874A patent/TW509667B/zh not_active IP Right Cessation
- 1999-03-12 PE PE1999000198A patent/PE20000339A1/es not_active Application Discontinuation
- 1999-03-15 AR ARP990101118A patent/AR017236A1/es unknown
- 1999-03-15 MY MYPI99000966A patent/MY121047A/en unknown
- 1999-03-16 DZ DZ990046A patent/DZ2745A1/xx active
- 1999-03-16 GT GT199900040A patent/GT199900040A/es unknown
- 1999-03-16 ZA ZA9902094A patent/ZA992094B/xx unknown
- 1999-03-16 MA MA25498A patent/MA26614A1/fr unknown
- 1999-03-16 TN TNTNSN99039A patent/TNSN99039A1/fr unknown
- 1999-03-17 CO CO99016567A patent/CO5090835A1/es unknown
- 1999-04-03 UA UA2000095327A patent/UA53781C2/uk unknown
2000
- 2000-08-18 IS IS5592A patent/IS5592A/is unknown
- 2000-09-15 NO NO20004626A patent/NO20004626L/no not_active Application Discontinuation
- 2000-09-18 OA OA1200000258A patent/OA11488A/en unknown
- 2000-10-11 BG BG104837A patent/BG104837A/bg unknown

Also Published As

Publication number	Publication date
EA200000842A1 (ru)	2001-04-23
AU753422B2 (en)	2002-10-17
IS5592A (is)	2000-08-18
US6136861A (en)	2000-10-24
DE69919142D1 (de)	2004-09-09
DZ2745A1 (fr)	2003-09-08
EP1064256A1 (en)	2001-01-03
NZ506227A (en)	2003-06-30
ES2224604T3 (es)	2005-03-01
IL138342A0 (en)	2001-10-31
PT1064256E (pt)	2004-10-29
PL343278A1 (en)	2001-08-13
BR9908850A (pt)	2000-11-21
WO1999047490A1 (en)	1999-09-23
JP2002506847A (ja)	2002-03-05
CA2321639C (en)	2005-08-02
AP1116A (en)	2002-10-21
KR20010041951A (ko)	2001-05-25
ATE272608T1 (de)	2004-08-15
HRP20000611A2 (en)	2001-04-30
SK13532000A3 (sk)	2002-07-02
TW509667B (en)	2002-11-11
CA2321639A1 (en)	1999-09-23
EA003946B1 (ru)	2003-10-30
TR200002671T2 (tr)	2000-12-21
PE20000339A1 (es)	2000-05-13
TNSN99039A1 (fr)	2005-11-10
GT199900040A (es)	2000-09-06
EP1064256B1 (en)	2004-08-04
NO20004626D0 (no)	2000-09-15
KR100372981B1 (ko)	2003-02-25
DE69919142T2 (de)	2005-01-20
CN1293655A (zh)	2001-05-02
UA53781C2 (uk)	2003-02-17
CN1231461C (zh)	2005-12-14
AP9901482A0 (en)	1999-03-31
HUP0101031A2 (hu)	2001-08-28
MA26614A1 (fr)	2004-12-20
OA11488A (en)	2004-05-07
JP3665567B2 (ja)	2005-06-29
NO20004626L (no)	2000-11-13
ZA992094B (en)	2000-11-28
AU2540999A (en)	1999-10-11
MY121047A (en)	2005-12-30
HUP0101031A3 (en)	2003-05-28
CO5090835A1 (es)	2001-10-30
BG104837A (bg)	2001-07-31
YU53700A (sh)	2002-11-15
CZ20003355A3 (cs)	2002-05-15
AR017236A1 (es)	2001-08-22

Publication	Publication Date	Title
ID25651A (id)	2000-10-19	Senyawa-senyawa bisiklo [2.2.1] heptana dan senyawa-senyawa yang terkait
ID29591A (id)	2001-09-06	Senyawa-senyawa kuinolina dan kuinoksalina
ID22957A (id)	1999-12-23	Senyawa dan penggunaannya
ID23575A (id)	2000-05-04	Pirazolopirimidina-pirazolopirimidina dan pirazolotriazina-pirazolotriazina
ID22889A (id)	1999-12-16	Komposisi kopolimer etilena dan penggunaannya
ID28846A (id)	2001-07-05	2-fenilbenzimidazol dan 2_fenilindol, pembuatan dan penggunaanya
DE69733395D1 (de)	2005-07-07	Motorzusammensetzung
ID23684A (id)	2000-05-11	Komposisi-polimer-organoclay dan pembuatannya
ID23439A (id)	2000-04-20	Turunan-turunan 3-piperidil-4-oksokuinazolin dan komposisi-komposisi farmasi yang sama
ID24196A (id)	2000-07-13	Komposisi dan penggunaan
NO996108D0 (no)	1999-12-10	9-oksinerytromycinderivater
DE69836248D1 (de)	2006-12-07	Wasser- und Ölabweisende Zusammensetzung
ID16889A (id)	1997-11-20	Senyawa turunan alkilaminobenzotiazol dan benzoksazol
ID20134A (id)	1998-10-08	Proses dan peralatan sintesis urea yang ditingkatkan
ID29052A (id)	2001-07-26	Turunan-turunan 3,3-biarilpiperidina dan 2,2-biarilmorfolina
ID16154A (id)	1997-09-04	Komposisi monomer yang distabilisasi
DE69740119D1 (de)	2011-03-24	Harnstoffschmierfettzusammensetzung
DE69613207D1 (de)	2001-07-12	Motor-Konstruktion
FIU960512U0 (fi)	1996-10-08	Moottorirakenne
BR9709521A (pt)	1999-08-10	"3-Cianoaril-pirazóis"
ID28967A (id)	2001-07-19	Benzisoksazol dan fenon sebagai alfa 2-antagonis
ID28278A (id)	2001-05-10	Komposisi pelembut-air dan deterjen
NO20005551D0 (no)	2000-11-03	2"-deoksyhygromycinderivater
BA96175A (bs)	2000-11-06	4-Tia-1-azabiciklo¬3.2.0.¾heptan-3- imino-2-izopropiliden-7-okso analogoni beta-laktama postupci priprave i upotreba
NO996127D0 (no)	1999-12-10	13-dihydro-3'-aziridino-antracykliner